文献速递肿瘤 PET/CT

基于PET/CT的肿块型肝内胆管癌影像组学改善病理数据与生存预测

PET/CT-based radiomics of mass-forming intrahepatic cholangiocarcinoma improves prediction of pathology data and survival.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2022-03-26

本研究回顾性纳入2010至2019年间术前接受[18F]FDG PET/CT检查并因肿块型肝内胆管癌行肝切除术的74例患者,提取肿瘤及瘤周5毫米区域的影像组学特征。结果显示,临床联合影像组学模型对肿瘤分级和微血管侵犯的预测优于纯临床模型,对总生存和无进展生存的预测优于纯术前临床模型,且与术后病理模型性能相近。

要点

  • 临床联合肿瘤影像组学模型预测肿瘤分级的AUC为0.78,优于纯临床模型的0.72。
  • 加入瘤周影像组学后预测肿瘤分级的AUC提升至0.83,但对微血管侵犯无进一步改善。
  • 临床联合肿瘤及瘤周影像组学模型预测总生存的C-index为0.81,优于纯临床模型的0.76。

核心结论

  • 基于PET的肝内胆管癌影像组学可预测病理数据,并实现术前对预后的可靠评估。
  • 肿瘤区域和瘤周区域的影像组学均具有临床相关性。
  • 临床联合影像组学模型优于纯术前临床模型,性能不劣于术后模型。

研究设计与样本

  • 回顾性评估2010至2019年间术前接受[18F]FDG PET/CT检查并因肿块型肝内胆管癌行肝切除术的全部患者。
  • 在PET图像上逐层手动分割肿瘤感兴趣区,并在肿瘤周围半自动生成5毫米边缘区域感兴趣区。
  • 使用LifeX软件进行纹理分析,分析结局包括肿瘤分级(G3 vs G1-2)、微血管侵犯、总生存和无进展生存。
  • 比较临床联合影像组学模型与标准临床模型的性能。
  • 共纳入74例患者,其中女性40例,中位年龄68岁。

主要发现

  • 对于肿瘤分级,临床联合肿瘤感兴趣区影像组学模型的AUC为0.78,优于纯临床模型的0.72。
  • 对于微血管侵犯,临床联合肿瘤感兴趣区影像组学模型的AUC为0.87,优于纯临床模型的0.78。
  • 将瘤周感兴趣区影像组学纳入模型后,肿瘤分级预测的AUC进一步提升至0.83,但微血管侵犯预测未进一步改善。
  • 对于总生存,包含术前临床数据及肿瘤和瘤周感兴趣区影像组学的模型C-index为0.81,优于纯临床模型的0.76,与包含病理和术后数据的模型C-index 0.81相近。
  • 对于无进展生存,包含术前临床数据及肿瘤和瘤周感兴趣区影像组学的模型C-index为0.81,优于纯临床模型的0.72,与包含病理和术后数据的模型C-index 0.79相近;没有模型保留标准SUV测量指标。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Intrahepatic cholangiocarcinoma (IHC) is an aggressive disease with few reliable preoperative biomarkers. This study aims to elucidate if radiomics extracted from preoperative [18F]FDG PET/CT may grant a non-invasive biological characterization of IHC and predict outcome after complete resection of the tumor. METHODS: All patients preoperatively imaged by [18F]FDG PET/CT who underwent hepatectomy for mass-forming IHC in the period 2010-2019 were retrospectively evaluated. On PET images, manual slice-by-slice segmentation of IHC was performed (Tumor-VOI). A 5-mm margin region was semi-automatically generated around the tumor (Margin-VOI). Textural analysis was performed using the LifeX software. Analyzed outcomes included tumor grading (G3 vs. G1-2), microvascular invasion (MVI), overall survival (OS), and progression-free survival (PFS). The performances of the combined clinical-radiomic models were compared with those of standard clinical models. RESULTS: Overall, 74 patients (40 females, median age 68 years) were included. Considering tumor grading and MVI, the models combining the clinical data and radiomics of the Tumor-VOI had better performances than the clinical ones (AUC = 0.78 vs. 0.72 for grading; 0.87 vs. 0.78 for MVI). The inclusion into the models of radiomics of the Margin-VOI further improved the prediction of grading (AUC = 0.83), but not of MVI. Considering OS and PFS, the models including the preoperative clinical data and radiomics of the Tumor-VOI and Margin-VOI had better performances than the pure clinical ones (C-index = 0.81 vs. 0.76 for OS; 0.81 vs. 0.72 for PFS) and similar to the models including the pathology and postoperative data (C-index = 0.81 for OS; 0.79 for PFS). No model retained the standard SUV measures. CONCLUSION: The PET-based radiomics of IHC can predict pathology data and allow a reliable preoperative evaluation of prognosis. The radiomics of both the tumoral and peritumoral areas had clinical relevance. The combined clinical-radiomic models outperformed the pure preoperative clinical ones and achieved performances non-inferior to the postoperative models.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Fiz F, Masci C, Costa G, et al. PET/CT-based radiomics of mass-forming intrahepatic cholangiocarcinoma improves prediction of pathology data and survival. Eur J Nucl Med Mol Imaging. 2022. PMID: 35347437. doi:10.1007/s00259-022-05765-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。